nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—SIGMAR1—Raloxifene—osteoporosis	0.578	1	CbGbCtD
Phentolamine—Pain in jaw—Zoledronate—osteoporosis	0.00918	0.0268	CcSEcCtD
Phentolamine—Peptic ulcer—Etidronic acid—osteoporosis	0.00754	0.022	CcSEcCtD
Phentolamine—Swelling face—Conjugated Estrogens—osteoporosis	0.00605	0.0177	CcSEcCtD
Phentolamine—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00525	1	CbGdCrCtD
Phentolamine—Injection site pain—Ibandronate—osteoporosis	0.00512	0.015	CcSEcCtD
Phentolamine—Tenderness—Estropipate—osteoporosis	0.005	0.0146	CcSEcCtD
Phentolamine—Tenderness—Raloxifene—osteoporosis	0.00484	0.0142	CcSEcCtD
Phentolamine—Blood pressure increased—Estropipate—osteoporosis	0.00436	0.0128	CcSEcCtD
Phentolamine—Blood pressure increased—Raloxifene—osteoporosis	0.00422	0.0124	CcSEcCtD
Phentolamine—Injection site reaction—Ibandronate—osteoporosis	0.00416	0.0122	CcSEcCtD
Phentolamine—Bradycardia—Calcium Acetate—osteoporosis	0.00392	0.0115	CcSEcCtD
Phentolamine—Blood pressure increased—Ethinyl Estradiol—osteoporosis	0.00353	0.0103	CcSEcCtD
Phentolamine—Arrhythmia—Calcium Acetate—osteoporosis	0.00344	0.0101	CcSEcCtD
Phentolamine—Tenderness—Conjugated Estrogens—osteoporosis	0.0033	0.00966	CcSEcCtD
Phentolamine—Injection site reaction—Zoledronate—osteoporosis	0.00297	0.0087	CcSEcCtD
Phentolamine—Blood pressure increased—Conjugated Estrogens—osteoporosis	0.00288	0.00843	CcSEcCtD
Phentolamine—Abdominal pain upper—Ibandronate—osteoporosis	0.00277	0.00811	CcSEcCtD
Phentolamine—Abdominal pain upper—Calcitriol—osteoporosis	0.00271	0.00794	CcSEcCtD
Phentolamine—Tenderness—Estradiol—osteoporosis	0.00264	0.00773	CcSEcCtD
Phentolamine—Hypertension—Ergocalciferol—osteoporosis	0.00256	0.00749	CcSEcCtD
Phentolamine—Hypotension—Calcium Acetate—osteoporosis	0.00256	0.00749	CcSEcCtD
Phentolamine—Paraesthesia—Calcium Acetate—osteoporosis	0.00246	0.00719	CcSEcCtD
Phentolamine—Acute coronary syndrome—Estropipate—osteoporosis	0.0024	0.00703	CcSEcCtD
Phentolamine—Myocardial infarction—Estropipate—osteoporosis	0.00239	0.00699	CcSEcCtD
Phentolamine—Pain—Calcium Acetate—osteoporosis	0.00234	0.00685	CcSEcCtD
Phentolamine—Blood pressure increased—Estradiol—osteoporosis	0.00231	0.00674	CcSEcCtD
Phentolamine—Abdominal pain upper—Risedronate—osteoporosis	0.00228	0.00668	CcSEcCtD
Phentolamine—Angina pectoris—Risedronate—osteoporosis	0.00211	0.00616	CcSEcCtD
Phentolamine—Pain—Ergocalciferol—osteoporosis	0.00207	0.00605	CcSEcCtD
Phentolamine—Cardiac disorder—Estropipate—osteoporosis	0.00203	0.00594	CcSEcCtD
Phentolamine—Angiopathy—Estropipate—osteoporosis	0.00199	0.00581	CcSEcCtD
Phentolamine—Abdominal pain upper—Zoledronate—osteoporosis	0.00198	0.0058	CcSEcCtD
Phentolamine—Mediastinal disorder—Estropipate—osteoporosis	0.00197	0.00577	CcSEcCtD
Phentolamine—Flushing—Raloxifene—osteoporosis	0.00197	0.00576	CcSEcCtD
Phentolamine—Cardiac disorder—Raloxifene—osteoporosis	0.00197	0.00576	CcSEcCtD
Phentolamine—Asthenia—Calcium Acetate—osteoporosis	0.00196	0.00575	CcSEcCtD
Phentolamine—Acute coronary syndrome—Ethinyl Estradiol—osteoporosis	0.00195	0.0057	CcSEcCtD
Phentolamine—Cardiac disorder—Ibandronate—osteoporosis	0.00195	0.0057	CcSEcCtD
Phentolamine—Myocardial infarction—Ethinyl Estradiol—osteoporosis	0.00194	0.00567	CcSEcCtD
Phentolamine—Pruritus—Calcium Acetate—osteoporosis	0.00194	0.00567	CcSEcCtD
Phentolamine—Angiopathy—Raloxifene—osteoporosis	0.00192	0.00563	CcSEcCtD
Phentolamine—Angiopathy—Ibandronate—osteoporosis	0.0019	0.00557	CcSEcCtD
Phentolamine—Mediastinal disorder—Ibandronate—osteoporosis	0.00189	0.00553	CcSEcCtD
Phentolamine—Diarrhoea—Calcium Acetate—osteoporosis	0.00187	0.00548	CcSEcCtD
Phentolamine—Nasal congestion—Estradiol—osteoporosis	0.00184	0.00537	CcSEcCtD
Phentolamine—Arrhythmia—Calcitriol—osteoporosis	0.00184	0.00537	CcSEcCtD
Phentolamine—Dizziness—Calcium Acetate—osteoporosis	0.00181	0.0053	CcSEcCtD
Phentolamine—Vomiting—Calcium Acetate—osteoporosis	0.00174	0.00509	CcSEcCtD
Phentolamine—Asthenia—Ergocalciferol—osteoporosis	0.00174	0.00508	CcSEcCtD
Phentolamine—Nausea—Calcium Acetate—osteoporosis	0.00163	0.00476	CcSEcCtD
Phentolamine—Paraesthesia—Etidronic acid—osteoporosis	0.00161	0.00472	CcSEcCtD
Phentolamine—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00161	0.00471	CcSEcCtD
Phentolamine—Cardiac disorder—Risedronate—osteoporosis	0.00161	0.0047	CcSEcCtD
Phentolamine—Chest pain—Alendronate—osteoporosis	0.0016	0.00467	CcSEcCtD
Phentolamine—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.00159	0.00465	CcSEcCtD
Phentolamine—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.00158	0.00462	CcSEcCtD
Phentolamine—Hypertension—Ibandronate—osteoporosis	0.00158	0.00462	CcSEcCtD
Phentolamine—Chest pain—Raloxifene—osteoporosis	0.00157	0.0046	CcSEcCtD
Phentolamine—Angiopathy—Risedronate—osteoporosis	0.00157	0.00459	CcSEcCtD
Phentolamine—Mediastinal disorder—Risedronate—osteoporosis	0.00156	0.00456	CcSEcCtD
Phentolamine—Chest pain—Ibandronate—osteoporosis	0.00156	0.00455	CcSEcCtD
Phentolamine—Arrhythmia—Risedronate—osteoporosis	0.00155	0.00452	CcSEcCtD
Phentolamine—Hypertension—Calcitriol—osteoporosis	0.00154	0.00452	CcSEcCtD
Phentolamine—Bradycardia—Zoledronate—osteoporosis	0.00153	0.00447	CcSEcCtD
Phentolamine—Abdominal pain upper—Estradiol—osteoporosis	0.00153	0.00447	CcSEcCtD
Phentolamine—Cardiac disorder—Pamidronate—osteoporosis	0.00153	0.00446	CcSEcCtD
Phentolamine—Flushing—Pamidronate—osteoporosis	0.00153	0.00446	CcSEcCtD
Phentolamine—Nervous system disorder—Estropipate—osteoporosis	0.00152	0.00446	CcSEcCtD
Phentolamine—Chest pain—Calcitriol—osteoporosis	0.00152	0.00445	CcSEcCtD
Phentolamine—Angiopathy—Pamidronate—osteoporosis	0.00149	0.00436	CcSEcCtD
Phentolamine—Mediastinal disorder—Pamidronate—osteoporosis	0.00148	0.00434	CcSEcCtD
Phentolamine—Nervous system disorder—Raloxifene—osteoporosis	0.00148	0.00432	CcSEcCtD
Phentolamine—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00147	0.0043	CcSEcCtD
Phentolamine—Nervous system disorder—Ibandronate—osteoporosis	0.00146	0.00428	CcSEcCtD
Phentolamine—Nausea—Ergocalciferol—osteoporosis	0.00144	0.0042	CcSEcCtD
Phentolamine—Abdominal pain—Etidronic acid—osteoporosis	0.00142	0.00416	CcSEcCtD
Phentolamine—Paraesthesia—Estropipate—osteoporosis	0.0014	0.00409	CcSEcCtD
Phentolamine—Cardiac disorder—Zoledronate—osteoporosis	0.00139	0.00408	CcSEcCtD
Phentolamine—Flushing—Zoledronate—osteoporosis	0.00139	0.00408	CcSEcCtD
Phentolamine—Angiopathy—Zoledronate—osteoporosis	0.00136	0.00399	CcSEcCtD
Phentolamine—Mediastinal disorder—Zoledronate—osteoporosis	0.00135	0.00396	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Estropipate—osteoporosis	0.00134	0.00393	CcSEcCtD
Phentolamine—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00134	0.00393	CcSEcCtD
Phentolamine—Arrhythmia—Zoledronate—osteoporosis	0.00134	0.00393	CcSEcCtD
Phentolamine—Paraesthesia—Ibandronate—osteoporosis	0.00134	0.00392	CcSEcCtD
Phentolamine—Pain—Estropipate—osteoporosis	0.00133	0.00389	CcSEcCtD
Phentolamine—Angiopathy—Conjugated Estrogens—osteoporosis	0.00131	0.00384	CcSEcCtD
Phentolamine—Pain—Alendronate—osteoporosis	0.00131	0.00383	CcSEcCtD
Phentolamine—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.0013	0.00381	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.0013	0.0038	CcSEcCtD
Phentolamine—Hypertension—Risedronate—osteoporosis	0.0013	0.0038	CcSEcCtD
Phentolamine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00129	0.00378	CcSEcCtD
Phentolamine—Pain—Raloxifene—osteoporosis	0.00129	0.00377	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00129	0.00377	CcSEcCtD
Phentolamine—Chest pain—Risedronate—osteoporosis	0.00128	0.00375	CcSEcCtD
Phentolamine—Pain—Ibandronate—osteoporosis	0.00128	0.00373	CcSEcCtD
Phentolamine—Pruritus—Etidronic acid—osteoporosis	0.00127	0.00372	CcSEcCtD
Phentolamine—Gastrointestinal pain—Estropipate—osteoporosis	0.00127	0.00372	CcSEcCtD
Phentolamine—Acute coronary syndrome—Estradiol—osteoporosis	0.00127	0.00372	CcSEcCtD
Phentolamine—Myocardial infarction—Estradiol—osteoporosis	0.00126	0.0037	CcSEcCtD
Phentolamine—Gastrointestinal pain—Alendronate—osteoporosis	0.00125	0.00366	CcSEcCtD
Phentolamine—Pain—Calcitriol—osteoporosis	0.00125	0.00365	CcSEcCtD
Phentolamine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00124	0.00362	CcSEcCtD
Phentolamine—Hypertension—Pamidronate—osteoporosis	0.00124	0.00362	CcSEcCtD
Phentolamine—Gastrointestinal pain—Raloxifene—osteoporosis	0.00123	0.0036	CcSEcCtD
Phentolamine—Diarrhoea—Etidronic acid—osteoporosis	0.00123	0.0036	CcSEcCtD
Phentolamine—Abdominal pain—Estropipate—osteoporosis	0.00123	0.0036	CcSEcCtD
Phentolamine—Gastrointestinal pain—Ibandronate—osteoporosis	0.00122	0.00357	CcSEcCtD
Phentolamine—Abdominal pain—Alendronate—osteoporosis	0.00121	0.00354	CcSEcCtD
Phentolamine—Nervous system disorder—Risedronate—osteoporosis	0.00121	0.00353	CcSEcCtD
Phentolamine—Gastrointestinal pain—Calcitriol—osteoporosis	0.00119	0.00349	CcSEcCtD
Phentolamine—Abdominal pain—Raloxifene—osteoporosis	0.00119	0.00348	CcSEcCtD
Phentolamine—Abdominal pain—Ibandronate—osteoporosis	0.00118	0.00345	CcSEcCtD
Phentolamine—Abdominal pain—Calcitriol—osteoporosis	0.00115	0.00338	CcSEcCtD
Phentolamine—Nervous system disorder—Pamidronate—osteoporosis	0.00115	0.00335	CcSEcCtD
Phentolamine—Vomiting—Etidronic acid—osteoporosis	0.00114	0.00334	CcSEcCtD
Phentolamine—Tachycardia—Pamidronate—osteoporosis	0.00114	0.00334	CcSEcCtD
Phentolamine—Hypertension—Zoledronate—osteoporosis	0.00113	0.0033	CcSEcCtD
Phentolamine—Headache—Etidronic acid—osteoporosis	0.00113	0.00329	CcSEcCtD
Phentolamine—Asthenia—Estropipate—osteoporosis	0.00112	0.00326	CcSEcCtD
Phentolamine—Chest pain—Zoledronate—osteoporosis	0.00111	0.00326	CcSEcCtD
Phentolamine—Paraesthesia—Risedronate—osteoporosis	0.0011	0.00323	CcSEcCtD
Phentolamine—Pruritus—Estropipate—osteoporosis	0.0011	0.00322	CcSEcCtD
Phentolamine—Asthenia—Alendronate—osteoporosis	0.0011	0.00321	CcSEcCtD
Phentolamine—Hypotension—Pamidronate—osteoporosis	0.00109	0.00319	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00109	0.00318	CcSEcCtD
Phentolamine—Pruritus—Alendronate—osteoporosis	0.00108	0.00317	CcSEcCtD
Phentolamine—Cardiac disorder—Estradiol—osteoporosis	0.00107	0.00314	CcSEcCtD
Phentolamine—Flushing—Estradiol—osteoporosis	0.00107	0.00314	CcSEcCtD
Phentolamine—Chest pain—Conjugated Estrogens—osteoporosis	0.00107	0.00314	CcSEcCtD
Phentolamine—Asthenia—Ibandronate—osteoporosis	0.00107	0.00313	CcSEcCtD
Phentolamine—Nausea—Etidronic acid—osteoporosis	0.00107	0.00312	CcSEcCtD
Phentolamine—Diarrhoea—Estropipate—osteoporosis	0.00106	0.00311	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Risedronate—osteoporosis	0.00106	0.0031	CcSEcCtD
Phentolamine—Pruritus—Ibandronate—osteoporosis	0.00106	0.00309	CcSEcCtD
Phentolamine—Pain—Risedronate—osteoporosis	0.00105	0.00307	CcSEcCtD
Phentolamine—Angiopathy—Estradiol—osteoporosis	0.00105	0.00307	CcSEcCtD
Phentolamine—Paraesthesia—Pamidronate—osteoporosis	0.00105	0.00307	CcSEcCtD
Phentolamine—Diarrhoea—Alendronate—osteoporosis	0.00105	0.00307	CcSEcCtD
Phentolamine—Asthenia—Calcitriol—osteoporosis	0.00105	0.00306	CcSEcCtD
Phentolamine—Nervous system disorder—Zoledronate—osteoporosis	0.00105	0.00306	CcSEcCtD
Phentolamine—Mediastinal disorder—Estradiol—osteoporosis	0.00104	0.00305	CcSEcCtD
Phentolamine—Tachycardia—Zoledronate—osteoporosis	0.00104	0.00305	CcSEcCtD
Phentolamine—Pruritus—Calcitriol—osteoporosis	0.00103	0.00302	CcSEcCtD
Phentolamine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00103	0.00302	CcSEcCtD
Phentolamine—Diarrhoea—Raloxifene—osteoporosis	0.00103	0.00302	CcSEcCtD
Phentolamine—Dizziness—Estropipate—osteoporosis	0.00103	0.00301	CcSEcCtD
Phentolamine—Diarrhoea—Ibandronate—osteoporosis	0.00102	0.00298	CcSEcCtD
Phentolamine—Dizziness—Alendronate—osteoporosis	0.00101	0.00296	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00101	0.00295	CcSEcCtD
Phentolamine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00101	0.00295	CcSEcCtD
Phentolamine—Gastrointestinal pain—Risedronate—osteoporosis	0.001	0.00294	CcSEcCtD
Phentolamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.001	0.00293	CcSEcCtD
Phentolamine—Pain—Pamidronate—osteoporosis	0.000999	0.00292	CcSEcCtD
Phentolamine—Diarrhoea—Calcitriol—osteoporosis	0.000999	0.00292	CcSEcCtD
Phentolamine—Hypotension—Zoledronate—osteoporosis	0.000997	0.00292	CcSEcCtD
Phentolamine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000996	0.00292	CcSEcCtD
Phentolamine—Dizziness—Raloxifene—osteoporosis	0.000996	0.00291	CcSEcCtD
Phentolamine—Vomiting—Estropipate—osteoporosis	0.000989	0.00289	CcSEcCtD
Phentolamine—Dizziness—Ibandronate—osteoporosis	0.000986	0.00288	CcSEcCtD
Phentolamine—Headache—Estropipate—osteoporosis	0.000974	0.00285	CcSEcCtD
Phentolamine—Vomiting—Alendronate—osteoporosis	0.000974	0.00285	CcSEcCtD
Phentolamine—Abdominal pain—Risedronate—osteoporosis	0.000971	0.00284	CcSEcCtD
Phentolamine—Hypotension—Conjugated Estrogens—osteoporosis	0.00096	0.00281	CcSEcCtD
Phentolamine—Headache—Alendronate—osteoporosis	0.000959	0.00281	CcSEcCtD
Phentolamine—Paraesthesia—Zoledronate—osteoporosis	0.000958	0.0028	CcSEcCtD
Phentolamine—Vomiting—Raloxifene—osteoporosis	0.000958	0.0028	CcSEcCtD
Phentolamine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000955	0.00279	CcSEcCtD
Phentolamine—Vomiting—Ibandronate—osteoporosis	0.000948	0.00277	CcSEcCtD
Phentolamine—Headache—Raloxifene—osteoporosis	0.000944	0.00276	CcSEcCtD
Phentolamine—Headache—Ibandronate—osteoporosis	0.000934	0.00273	CcSEcCtD
Phentolamine—Vomiting—Calcitriol—osteoporosis	0.000928	0.00272	CcSEcCtD
Phentolamine—Nausea—Estropipate—osteoporosis	0.000924	0.0027	CcSEcCtD
Phentolamine—Abdominal pain—Pamidronate—osteoporosis	0.000924	0.0027	CcSEcCtD
Phentolamine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000923	0.0027	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000921	0.0027	CcSEcCtD
Phentolamine—Headache—Calcitriol—osteoporosis	0.000914	0.00268	CcSEcCtD
Phentolamine—Pain—Zoledronate—osteoporosis	0.000913	0.00267	CcSEcCtD
Phentolamine—Nausea—Alendronate—osteoporosis	0.00091	0.00266	CcSEcCtD
Phentolamine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000904	0.00265	CcSEcCtD
Phentolamine—Nausea—Raloxifene—osteoporosis	0.000895	0.00262	CcSEcCtD
Phentolamine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000892	0.00261	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000887	0.0026	CcSEcCtD
Phentolamine—Nausea—Ibandronate—osteoporosis	0.000886	0.00259	CcSEcCtD
Phentolamine—Asthenia—Risedronate—osteoporosis	0.000882	0.00258	CcSEcCtD
Phentolamine—Pain—Conjugated Estrogens—osteoporosis	0.000879	0.00257	CcSEcCtD
Phentolamine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000873	0.00255	CcSEcCtD
Phentolamine—Hypertension—Estradiol—osteoporosis	0.00087	0.00255	CcSEcCtD
Phentolamine—Pruritus—Risedronate—osteoporosis	0.000869	0.00254	CcSEcCtD
Phentolamine—Nausea—Calcitriol—osteoporosis	0.000867	0.00254	CcSEcCtD
Phentolamine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000862	0.00252	CcSEcCtD
Phentolamine—Chest pain—Estradiol—osteoporosis	0.000858	0.00251	CcSEcCtD
Phentolamine—Abdominal pain—Zoledronate—osteoporosis	0.000844	0.00247	CcSEcCtD
Phentolamine—Diarrhoea—Risedronate—osteoporosis	0.000841	0.00246	CcSEcCtD
Phentolamine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00084	0.00246	CcSEcCtD
Phentolamine—Asthenia—Pamidronate—osteoporosis	0.000838	0.00245	CcSEcCtD
Phentolamine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000834	0.00244	CcSEcCtD
Phentolamine—Pruritus—Pamidronate—osteoporosis	0.000827	0.00242	CcSEcCtD
Phentolamine—Dizziness—Risedronate—osteoporosis	0.000813	0.00238	CcSEcCtD
Phentolamine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000812	0.00238	CcSEcCtD
Phentolamine—Nervous system disorder—Estradiol—osteoporosis	0.000806	0.00236	CcSEcCtD
Phentolamine—Tachycardia—Estradiol—osteoporosis	0.000803	0.00235	CcSEcCtD
Phentolamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000801	0.00234	CcSEcCtD
Phentolamine—Diarrhoea—Pamidronate—osteoporosis	0.000799	0.00234	CcSEcCtD
Phentolamine—Headache—Ethinyl Estradiol—osteoporosis	0.00079	0.00231	CcSEcCtD
Phentolamine—Vomiting—Risedronate—osteoporosis	0.000781	0.00229	CcSEcCtD
Phentolamine—Dizziness—Pamidronate—osteoporosis	0.000773	0.00226	CcSEcCtD
Phentolamine—Headache—Risedronate—osteoporosis	0.00077	0.00225	CcSEcCtD
Phentolamine—Asthenia—Zoledronate—osteoporosis	0.000766	0.00224	CcSEcCtD
Phentolamine—Pruritus—Zoledronate—osteoporosis	0.000755	0.00221	CcSEcCtD
Phentolamine—Nausea—Ethinyl Estradiol—osteoporosis	0.000749	0.00219	CcSEcCtD
Phentolamine—Vomiting—Pamidronate—osteoporosis	0.000743	0.00217	CcSEcCtD
Phentolamine—Paraesthesia—Estradiol—osteoporosis	0.000738	0.00216	CcSEcCtD
Phentolamine—Asthenia—Conjugated Estrogens—osteoporosis	0.000737	0.00216	CcSEcCtD
Phentolamine—Headache—Pamidronate—osteoporosis	0.000732	0.00214	CcSEcCtD
Phentolamine—Diarrhoea—Zoledronate—osteoporosis	0.00073	0.00214	CcSEcCtD
Phentolamine—Nausea—Risedronate—osteoporosis	0.00073	0.00214	CcSEcCtD
Phentolamine—Pruritus—Conjugated Estrogens—osteoporosis	0.000727	0.00213	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Estradiol—osteoporosis	0.00071	0.00208	CcSEcCtD
Phentolamine—Dizziness—Zoledronate—osteoporosis	0.000706	0.00206	CcSEcCtD
Phentolamine—Pain—Estradiol—osteoporosis	0.000703	0.00206	CcSEcCtD
Phentolamine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000703	0.00206	CcSEcCtD
Phentolamine—Nausea—Pamidronate—osteoporosis	0.000694	0.00203	CcSEcCtD
Phentolamine—Dizziness—Conjugated Estrogens—osteoporosis	0.000679	0.00199	CcSEcCtD
Phentolamine—Vomiting—Zoledronate—osteoporosis	0.000678	0.00198	CcSEcCtD
Phentolamine—Gastrointestinal pain—Estradiol—osteoporosis	0.000672	0.00197	CcSEcCtD
Phentolamine—Headache—Zoledronate—osteoporosis	0.000668	0.00196	CcSEcCtD
Phentolamine—Vomiting—Conjugated Estrogens—osteoporosis	0.000653	0.00191	CcSEcCtD
Phentolamine—Abdominal pain—Estradiol—osteoporosis	0.00065	0.0019	CcSEcCtD
Phentolamine—Headache—Conjugated Estrogens—osteoporosis	0.000644	0.00188	CcSEcCtD
Phentolamine—Nausea—Zoledronate—osteoporosis	0.000634	0.00185	CcSEcCtD
Phentolamine—Nausea—Conjugated Estrogens—osteoporosis	0.00061	0.00179	CcSEcCtD
Phentolamine—Asthenia—Estradiol—osteoporosis	0.00059	0.00173	CcSEcCtD
Phentolamine—Pruritus—Estradiol—osteoporosis	0.000582	0.0017	CcSEcCtD
Phentolamine—Diarrhoea—Estradiol—osteoporosis	0.000563	0.00165	CcSEcCtD
Phentolamine—Dizziness—Estradiol—osteoporosis	0.000544	0.00159	CcSEcCtD
Phentolamine—Vomiting—Estradiol—osteoporosis	0.000523	0.00153	CcSEcCtD
Phentolamine—Headache—Estradiol—osteoporosis	0.000515	0.00151	CcSEcCtD
Phentolamine—Nausea—Estradiol—osteoporosis	0.000488	0.00143	CcSEcCtD
Phentolamine—ADRA1A—Signaling Pathways—LRP6—osteoporosis	5.95e-05	0.000793	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—P4HB—osteoporosis	5.92e-05	0.000789	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MGLL—osteoporosis	5.92e-05	0.000789	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—PTHLH—osteoporosis	5.91e-05	0.000787	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—P4HB—osteoporosis	5.87e-05	0.000783	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CALCA—osteoporosis	5.86e-05	0.00078	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GAPDH—osteoporosis	5.81e-05	0.000775	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—LRP5—osteoporosis	5.78e-05	0.00077	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TLN1—osteoporosis	5.74e-05	0.000766	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CALCA—osteoporosis	5.73e-05	0.000763	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PTH—osteoporosis	5.71e-05	0.000761	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—RAP1A—osteoporosis	5.66e-05	0.000755	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CYP27A1—osteoporosis	5.66e-05	0.000754	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TLN1—osteoporosis	5.65e-05	0.000753	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RAP1A—osteoporosis	5.61e-05	0.000748	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—IGF1—osteoporosis	5.59e-05	0.000744	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CNR2—osteoporosis	5.57e-05	0.000742	CbGpPWpGaD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	5.54e-05	0.000739	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—ADCY5—osteoporosis	5.53e-05	0.000737	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—LRP6—osteoporosis	5.53e-05	0.000736	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ACP5—osteoporosis	5.5e-05	0.000734	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	5.49e-05	0.000732	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NFATC1—osteoporosis	5.48e-05	0.00073	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—DKK1—osteoporosis	5.43e-05	0.000724	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	5.32e-05	0.000709	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—POMC—osteoporosis	5.3e-05	0.000707	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—P4HB—osteoporosis	5.3e-05	0.000707	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—WNT1—osteoporosis	5.23e-05	0.000698	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—IGF1—osteoporosis	5.22e-05	0.000695	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CALCA—osteoporosis	5.2e-05	0.000693	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PTH—osteoporosis	5.16e-05	0.000687	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—TPI1—osteoporosis	5.12e-05	0.000682	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—FGA—osteoporosis	5.09e-05	0.000679	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RAP1A—osteoporosis	5.07e-05	0.000676	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CNR2—osteoporosis	5.03e-05	0.00067	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TLN1—osteoporosis	5.02e-05	0.000669	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—ADCY5—osteoporosis	5.02e-05	0.000669	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—ADCY5—osteoporosis	4.99e-05	0.000665	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—P4HB—osteoporosis	4.95e-05	0.00066	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NFATC1—osteoporosis	4.94e-05	0.000659	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	4.93e-05	0.000657	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—POMC—osteoporosis	4.93e-05	0.000657	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—DKK1—osteoporosis	4.91e-05	0.000654	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—P4HB—osteoporosis	4.87e-05	0.00065	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	4.83e-05	0.000644	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PTH—osteoporosis	4.82e-05	0.000642	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—P4HB—osteoporosis	4.81e-05	0.000641	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PTH—osteoporosis	4.74e-05	0.000632	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RAP1A—osteoporosis	4.73e-05	0.000631	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PTHLH—osteoporosis	4.73e-05	0.000631	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—BMP2—osteoporosis	4.73e-05	0.000631	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—WNT1—osteoporosis	4.73e-05	0.00063	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GAPDH—osteoporosis	4.72e-05	0.000629	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CNR2—osteoporosis	4.7e-05	0.000626	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TLN1—osteoporosis	4.67e-05	0.000622	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—ADCY5—osteoporosis	4.66e-05	0.000621	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RAP1A—osteoporosis	4.66e-05	0.000621	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—FGB—osteoporosis	4.63e-05	0.000617	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CNR2—osteoporosis	4.62e-05	0.000616	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NFATC1—osteoporosis	4.62e-05	0.000616	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.6e-05	0.000613	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—RAP1A—osteoporosis	4.6e-05	0.000613	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—FGA—osteoporosis	4.6e-05	0.000613	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—ADCY5—osteoporosis	4.59e-05	0.000611	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—DKK1—osteoporosis	4.58e-05	0.000611	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ENO1—osteoporosis	4.58e-05	0.00061	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NFATC1—osteoporosis	4.55e-05	0.000606	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—ADCY5—osteoporosis	4.53e-05	0.000604	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PSMA2—osteoporosis	4.51e-05	0.000601	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PSMA5—osteoporosis	4.51e-05	0.000601	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—DKK1—osteoporosis	4.51e-05	0.000601	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PSMA2—osteoporosis	4.47e-05	0.000596	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PSMA5—osteoporosis	4.47e-05	0.000596	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—WNT1—osteoporosis	4.41e-05	0.000588	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—WNT1—osteoporosis	4.34e-05	0.000579	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—P4HB—osteoporosis	4.33e-05	0.000577	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—FGA—osteoporosis	4.29e-05	0.000572	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PTHLH—osteoporosis	4.27e-05	0.00057	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—BMP2—osteoporosis	4.27e-05	0.00057	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—IGF1—osteoporosis	4.24e-05	0.000565	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—ADCY5—osteoporosis	4.23e-05	0.000564	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—FGA—osteoporosis	4.23e-05	0.000563	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PTH—osteoporosis	4.21e-05	0.000561	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—FGB—osteoporosis	4.18e-05	0.000557	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CALCA—osteoporosis	4.17e-05	0.000556	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—ADCY5—osteoporosis	4.17e-05	0.000555	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	4.14e-05	0.000552	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CNR2—osteoporosis	4.1e-05	0.000547	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.09e-05	0.000545	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	4.07e-05	0.000543	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—POMC—osteoporosis	4.06e-05	0.000542	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	4.04e-05	0.000538	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PSMA5—osteoporosis	4.04e-05	0.000538	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PSMA2—osteoporosis	4.04e-05	0.000538	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—P4HB—osteoporosis	4.02e-05	0.000536	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—DKK1—osteoporosis	4.01e-05	0.000534	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PTHLH—osteoporosis	3.99e-05	0.000532	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—BMP2—osteoporosis	3.99e-05	0.000532	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PTHLH—osteoporosis	3.93e-05	0.000524	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—BMP2—osteoporosis	3.93e-05	0.000524	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PTH—osteoporosis	3.91e-05	0.000522	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—FGB—osteoporosis	3.91e-05	0.000521	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—WNT1—osteoporosis	3.86e-05	0.000514	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	3.85e-05	0.000513	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—FGB—osteoporosis	3.84e-05	0.000512	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CNR2—osteoporosis	3.81e-05	0.000508	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	3.79e-05	0.000505	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—KL—osteoporosis	3.78e-05	0.000504	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PSMA2—osteoporosis	3.77e-05	0.000503	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PSMA5—osteoporosis	3.77e-05	0.000503	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CALCA—osteoporosis	3.76e-05	0.000502	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FGA—osteoporosis	3.75e-05	0.0005	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	3.75e-05	0.0005	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—DKK1—osteoporosis	3.72e-05	0.000496	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ENO1—osteoporosis	3.72e-05	0.000496	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PSMA2—osteoporosis	3.71e-05	0.000495	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PSMA5—osteoporosis	3.71e-05	0.000495	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	3.7e-05	0.000493	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—POMC—osteoporosis	3.69e-05	0.000492	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—POMC—osteoporosis	3.67e-05	0.000489	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PSMA5—osteoporosis	3.66e-05	0.000488	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PSMA2—osteoporosis	3.66e-05	0.000488	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CYP19A1—osteoporosis	3.66e-05	0.000488	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6R—osteoporosis	3.6e-05	0.00048	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—WNT1—osteoporosis	3.59e-05	0.000478	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CALCA—osteoporosis	3.51e-05	0.000468	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	3.49e-05	0.000465	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—BMP2—osteoporosis	3.49e-05	0.000465	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FGA—osteoporosis	3.49e-05	0.000465	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CALCA—osteoporosis	3.46e-05	0.000461	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	3.44e-05	0.000458	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	3.43e-05	0.000457	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—KL—osteoporosis	3.42e-05	0.000455	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FGB—osteoporosis	3.42e-05	0.000455	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	3.37e-05	0.00045	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—TGFB1—osteoporosis	3.35e-05	0.000446	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—POMC—osteoporosis	3.33e-05	0.000444	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	3.3e-05	0.000439	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	3.3e-05	0.000439	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	3.25e-05	0.000433	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	3.24e-05	0.000432	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	3.24e-05	0.000432	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—KL—osteoporosis	3.19e-05	0.000425	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FGB—osteoporosis	3.17e-05	0.000423	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—KL—osteoporosis	3.14e-05	0.000419	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—TGFB1—osteoporosis	3.13e-05	0.000417	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—POMC—osteoporosis	3.11e-05	0.000415	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CALCA—osteoporosis	3.07e-05	0.00041	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—POMC—osteoporosis	3.06e-05	0.000408	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	3.06e-05	0.000408	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	3.06e-05	0.000408	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	3.04e-05	0.000405	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	3e-05	0.000399	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ADCY5—osteoporosis	2.99e-05	0.000399	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	2.99e-05	0.000398	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GPX1—osteoporosis	2.98e-05	0.000397	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CYP19A1—osteoporosis	2.97e-05	0.000396	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ADCY5—osteoporosis	2.96e-05	0.000395	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SPP1—osteoporosis	2.87e-05	0.000382	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	2.85e-05	0.000381	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—KL—osteoporosis	2.79e-05	0.000372	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	2.78e-05	0.000371	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—MTHFR—osteoporosis	2.75e-05	0.000367	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—POMC—osteoporosis	2.72e-05	0.000363	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	2.68e-05	0.000357	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	2.65e-05	0.000354	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IRS2—osteoporosis	2.59e-05	0.000346	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—KL—osteoporosis	2.59e-05	0.000346	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SPP1—osteoporosis	2.59e-05	0.000345	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TGFB1—osteoporosis	2.54e-05	0.000339	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—LEP—osteoporosis	2.54e-05	0.000338	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	2.53e-05	0.000337	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	2.5e-05	0.000333	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	2.47e-05	0.000329	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	2.46e-05	0.000328	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ADCY5—osteoporosis	2.43e-05	0.000324	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ESR1—osteoporosis	2.42e-05	0.000323	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GPX1—osteoporosis	2.42e-05	0.000323	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SPP1—osteoporosis	2.42e-05	0.000322	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	2.38e-05	0.000317	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	2.34e-05	0.000312	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—LEP—osteoporosis	2.29e-05	0.000305	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IRS1—osteoporosis	2.26e-05	0.000302	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—MTHFR—osteoporosis	2.23e-05	0.000298	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—POMC—osteoporosis	2.2e-05	0.000293	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	2.19e-05	0.000292	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IRS2—osteoporosis	2.19e-05	0.000292	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	2.19e-05	0.000291	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—POMC—osteoporosis	2.18e-05	0.000291	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	2.15e-05	0.000287	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—LEP—osteoporosis	2.14e-05	0.000285	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6R—osteoporosis	2.13e-05	0.000284	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	2.11e-05	0.000282	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—LEP—osteoporosis	2.11e-05	0.000281	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IGF1—osteoporosis	2.1e-05	0.00028	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	2.04e-05	0.000272	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ESR1—osteoporosis	2.04e-05	0.000272	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	2.03e-05	0.000271	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	2.01e-05	0.000268	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.97e-05	0.000262	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.96e-05	0.000262	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.92e-05	0.000256	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.91e-05	0.000255	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IRS1—osteoporosis	1.91e-05	0.000255	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	1.89e-05	0.000252	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1.88e-05	0.00025	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.87e-05	0.000249	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—POMC—osteoporosis	1.84e-05	0.000245	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—POMC—osteoporosis	1.81e-05	0.000241	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6R—osteoporosis	1.79e-05	0.000239	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.79e-05	0.000238	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—POMC—osteoporosis	1.79e-05	0.000238	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.78e-05	0.000237	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IGF1—osteoporosis	1.77e-05	0.000236	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	1.77e-05	0.000235	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	1.74e-05	0.000232	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.74e-05	0.000232	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.67e-05	0.000223	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.66e-05	0.000221	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—POMC—osteoporosis	1.61e-05	0.000214	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—osteoporosis	1.6e-05	0.000214	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	1.57e-05	0.000209	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.55e-05	0.000207	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	1.55e-05	0.000206	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.49e-05	0.000199	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.46e-05	0.000194	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	1.45e-05	0.000193	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.44e-05	0.000191	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—osteoporosis	1.35e-05	0.00018	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	1.33e-05	0.000177	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MYC—osteoporosis	1.26e-05	0.000168	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	1.26e-05	0.000168	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	1.18e-05	0.000158	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MYC—osteoporosis	1.14e-05	0.000152	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	1.14e-05	0.000151	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	1.1e-05	0.000146	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MYC—osteoporosis	1.06e-05	0.000142	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	1.06e-05	0.000141	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MYC—osteoporosis	1.05e-05	0.000139	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	1.04e-05	0.000139	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—osteoporosis	9.48e-06	0.000126	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MYC—osteoporosis	9.29e-06	0.000124	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	9.27e-06	0.000124	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MYC—osteoporosis	8.63e-06	0.000115	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	8.61e-06	0.000115	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—osteoporosis	8.55e-06	0.000114	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—osteoporosis	7.99e-06	0.000107	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—osteoporosis	7.86e-06	0.000105	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—osteoporosis	6.99e-06	9.31e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—osteoporosis	6.49e-06	8.65e-05	CbGpPWpGaD
